Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
thrombin inhibitor |
| gptkbp:CASNumber |
144167-51-9
|
| gptkbp:category |
investigational drug
|
| gptkbp:developedBy |
gptkb:Boehringer_Ingelheim
|
| gptkbp:hasMolecularFormula |
C20H22N6O2
|
| gptkbp:hasSMILES |
C1COCCN1CC2=CC=CC=C2NC(=O)NC3=CC=CC=N3
|
| https://www.w3.org/2000/01/rdf-schema#label |
BIBR 1048
|
| gptkbp:IUPACName |
N-(2-pyridinyl)-N-[1-(4-morpholinylmethyl)benzyl]urea
|
| gptkbp:mechanismOfAction |
direct thrombin inhibition
|
| gptkbp:PubChem_CID |
CHEMBL2105932
132982 |
| gptkbp:relatedTo |
gptkb:dabigatran
|
| gptkbp:target |
gptkb:thrombin
|
| gptkbp:used_in_research_for |
anticoagulation
|
| gptkbp:bfsParent |
gptkb:DB09054
|
| gptkbp:bfsLayer |
6
|